Clinical trials: Vancomycin Treatment
- Condition Vancomycin Treatment
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Vancomycin-Resistant Enterococcal Colonization
Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy and VRE-Colonized Subjects
The study is a first-in-human Phase 1/2a randomized, double-blind, placebo-controlled trial to assess the clinical safety and efficacy of VRELysin in healthy and VRE-colonized adults.
- Trial name
- NCT05715619
- Testing
- VRELysin™
- Where
- United States
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Intralytix, Inc.
Healthy Volunteers
First-in-human Study of VE303 in Healthy Adult Volunteers
This study was designed to evaluate safety and tolerability of a range of doses of VE303 in healthy adult volunteers. The study also evaluated pharmacokinetics of intestinal colonization by the VE303 strains and pharmacodynamics…
- Trial name
- NCT04236778
- Testing
- VE303, Oral Vancomycin
- Where
- United States
- Volunteers
- 39 people, healthy volunteers welcome
- Sponsor
- Vedanta Biosciences, Inc.